Cyclerion Therapeutics to Participate in Jefferies Virtual Healthcare Conference
May 25 2021 - 6:00AM
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that
Company management will present a corporate overview at the
Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at
4:00 p.m. ET. Management will also be available for one-on-one
meetings and investors may request a meeting through Jefferies.
The live webcast can be accessed via the
Investors & Media section of the Cyclerion website at
https://ir.cyclerion.com/news-events/event-calendar. An archived
replay of the event will be available on the site for approximately
90 days following the presentation.
About Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage
biopharmaceutical company on a mission to develop treatments that
restore cognitive function. Cyclerion’ is advancing novel,
first-in-class, CNS-penetrant, sGC stimulators that modulate a key
node in a fundamental CNS signaling pathway. The multidimensional
pharmacology elicited by the stimulation of sGC has the potential
to impact a broad range of CNS diseases. The most advanced
compound, CY6463 has shown rapid improvement in biomarkers
associated with cognitive function and is currently in clinical
development for Alzheimer's Disease with Vascular pathology (ADv)
and Mitochondrial Encephalomyopathy, Lactic Acidosis and
Stroke-like episodes (MELAS) and Cognitive Impairment Associated
with Schizophrenia (CIAS). Cyclerion is also advancing CY3018, a
next generation sGC stimulator.
For more information about Cyclerion, please
visit https://www.cyclerion.com/ and follow us on Twitter
(@Cyclerion) and LinkedIn (www.linkedin.com/company/cyclerion).
InvestorsCarlo Tanzi, Ph.D.Kendall Investor
Relationsctanzi@kendallir.com
MediaAmanda SellersVerge Scientific
Communicationsasellers@vergescientific.com
Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From Apr 2024 to May 2024
Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From May 2023 to May 2024